A Florida woman is bringing a wrongful death lawsuit on behalf of deceased loved one claiming that Janssen Pharmaceuticals and dangerous Xarelto side effects are responsible for her death.

Plaintiff Amy P. has recently filed a lawsuit on behalf of herself and as a personal representative of the estate of Carolyn H. who is now deceased.

Xarelto has been the subject of many personal injury lawsuits that claim the drug causes internal bleeding that does not have an antidote.

Dangerous Xarelto Side Effects Lawsuit

The decedent, Carolyn, used Xarelto (rivaroxaban) to reduce the risk of stroke and systemic embolism. She was prescribed Xarelto in July 2014 upon the direction of her physician for the treatment of atrial fibrillation.

However, in March, Carolyn suffered from a gastrointestinal bleed and experienced a life-threatening, irreversible bleed from Xarelto, Amy claims. Carolyn also suffered from severe pain and suffering.

Amy claims that as a direct and proximate result of Xarelto use, Carolyn suffered serious and dangerous Xarelto side effects including life-threatening bleeding as well as other severe and personal injuries which are permanent and lasting in nature.

She also experienced physical pain and mental anguish including diminished enjoyment of life, expenses for hospitalization and medical treatment and loss of earnings.

Amy claims in this dangerous Xarelto side effects lawsuit that the decedent has suffered and incurred damages including medical expenses, the loss of accumulations and other economic and non-economic damages.

According to this Xarelto side effects lawsuit, Janssen and the other named defendants were responsible for the design, research, manufacture, testing, advertising, promotion, marketing, sale and distribution of Xarelto.

Xarelto’s primary use is to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, to treat DVT and PE, to reduce the risk of recurrence of DVT and/or PE, and for prophylaxis of DVT for patients undergoing hip and knee replacement surgery.

The Food and Drug Administration approved Xarelto for use in July 2011. Later that year in November 2011, Xarelto was also approved for patients to reduce their risk of stroke and systemic embolism.

In less than one year after Xarelto was approved, there were more than one thousand serious reports of Xarelto side effects reported by consumers to the FDA. All of these Xarelto side effects involved bleeding problems.

Of the 1,080 adverse event reports, more than 60 were fatalities. By the end of that year, there were over 2,000 serious Xarelto side effects adverse event reports and 151 deaths.

In Germany, regulators received nearly 1,000 additional adverse event reports that same year including 72 fatalities.

Amy is holding Janssen responsible for the death of Carolyn. Her Xarelto side effects lawsuit raises claims of negligence, strict products liability, breach of express warranty, breach of implied warranty, fraudulent misrepresentation, fraudulent concealment, negligent misrepresentation, fraud and deceit and violation of consumer protection laws.

The Dangerous Xarelto Side Effects Lawsuit is Case No. 2:16-cv-16268 in the U.S. District Court of the Eastern District of Louisiana.